Dr John Rothman
https://www.raceoncology.com/staff/dr-john-rothman/
Has popped up on the shareholding list ... at number 6 at 1.8m shares after the Aug Annual Report. Wasn't present prior.
Things will have changed a little since ... but yet another intriguing fact. Another heavyweight for a miniscule biotech co still only $11m Cap ... I expect the assets of the directors/staff now outweigh the Cap of the Co by 10:1 !!! lol
Dr John Rothman was a clinical scientist at the pharmaceutical companies, Schering Plough and Roche, where he was also a Clinical Director for a number of different therapeutic areas and Senior Director for all of Roche’s data acquisition, statistical analysis and report writing for all experimental and approved drugs in the Roche portfolio.
RAC Charts, page-177
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.89 |
Change
0.120(6.80%) |
Mkt cap ! $321.0M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.93 | $1.78 | $563.4K | 302.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 108 | $1.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 4926 | 1 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |